Clinical Trial Detail

NCT ID NCT01620190
Title Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

lung non-small cell carcinoma

Therapies

Nab-paclitaxel

Age Groups: adult senior

No variant requirements are available.